Expression of matrix metalloproteinases in ovarian endometriomas: immunohistochemical study and enzyme immunoassay
article
OA: closed
CC0
⤵ 34 in-corpus citations
AI-generated summary
This study investigated the expression of matrix metalloproteinases in ovarian endometriomas using immunohistochemistry and enzyme immunoassay to reveal their presence and levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Like carcinoma, endometriosis has the unique characteristics, of invasion and metastasis, though pathologically, it is a benign tumor. However, the mechanism of destruction of the surrounding tissue in endometriosis is still unclear. In this study, the expression and localization of matrix metalloproteinases (MMP)-1, -2, -3, -7, -9 and tissue inhibitors of metalloproteinases-1 (TIMP-1) were evaluated by immunohistochemistry for 20 cases and the amounts of MMP-1, TIMP-1 and MMP-1/TIMP-1 complex in the fluid of endometrioma, were analyzed by ELISA and western blotting for 20 cases, which were analyzed by immunohistochemical study. MMP-1, -2 and -9 were detected strongly in both stromal and epithelial cells and MMP-7 in the epithelial cells in the menstrual period. MMP-3 was mainly expressed in macrophage containing hemosiderin but the change of expression was not clear. TIMP-1 was intensively detected in both stromal and epithelial cells in the menstrual period but the expression decreased in other stages of the menstrual cycle. ELISA for MMP-1 also showed results similar to immunohistochemistry, suggesting that it was released to the cyst in the menstrual period when it was released to the extracellular space from the cytoplasm. The expression of TIMP-1 was not clearly changed during the menstrual cycle. From these results, it was suggested that the destruction of the surrounding matrix by endometriosis might be caused by various MMPs, which are mainly produced in stromal cells.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- Expression of estrogen and progesterone receptors and their mRNAs in ovarian endometriosis via openalex
- Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions via openalex
- [Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol]. via openalex
- Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium via openalex
- Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis via openalex
- Immunohistochemical localization of granulocyte-macrophage colony-stimulating factor in matched endometriosis and endometrial tissues via openalex
- Increased chemotactic activity of peritoneal fluid in patients with endometriosis via openalex
- Localization of Matrix Metalloproteinase-2 in Uterine Endometrium and Ectopic Implants via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Matrix Metalloproteinases and Tace Play A Role in The Pathogenesis of Endometriosis via openalex
- Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis via openalex
- W2021293531 via openalex
- W2054771813 via openalex
- W2064494203 via openalex
- W2084175887 via openalex
- W2090197643 via openalex
- W2094383633 via openalex
- W2096190665 via openalex
- W2133991093 via openalex
- W2145474459 via openalex
- W2154899220 via openalex
- W2431574917 via openalex
- W4249934457 via openalex
- W6644465346 via openalex
- W6682451558 via openalex
- W201339084 via openalex
- W6831699418 via openalex
- W1965935112 via openalex
- W1969455800 via openalex
- W1972441006 via openalex
- W1977060444 via openalex
- W1980638951 via openalex
- W1986075242 via openalex
- W1991147086 via openalex
- W1992084421 via openalex
- W2000903132 via openalex
- W2020787235 via openalex
Cited by (35)
- Beyond the Mass Effect: Decoupling Endometrioma Size and Bilaterality from Ovarian Reserve Depletion 2026
- MMP-9 and TIMP-1 Promote Extracellular Matrix Remodeling in the Formation of Ovarian Endometrioma: in vitro Study on Chicken Chorioallantoic Membrane 2023
- Serum kisspeptin levels in deep-infiltrating, ovarian, and superficial endometriosis: A prospective observational study 2022
- IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression 2022
- Menstruation Dysregulation and Endometriosis Development 2021
- Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? 2019
- The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) 2018
- The gametotoxic effects of the endometrioma content: insights from a parthenogenetic human model 2018
- Complex Mechanisms of Matrix Metalloproteinases Involvement in Endometrial Physiology and Pathology—An Update 2017
- DNA Microarray Analysis of Gene Expression in Eutopic Endometrium from Patients with Endometriosis 2017
- Traitement conservateur des endométriomes chez les patientes prises en charge en FIV 2017
- Intracellular Wnt/Beta-Catenin Signaling Underlying 17beta-Estradiol-Induced Matrix Metalloproteinase 9 Expression in Human Endometriosis1 2016
- Are matrix metalloproteinases and their inhibitors reliable diagnosis biomarkers and attractive therapeutic targets in endometriosis? 2016
- A new approach to the management of ovarian endometrioma to prevent tissue damage and recurrence 2016
- Syndecan-4 expression is upregulated in endometriosis and contributes to an invasive phenotype 2016
- IVF outcome in women with accidental contamination of follicular fluid with endometrioma content 2014
- KISS1/KISS1R expression in eutopic and ectopic endometrium of women suffering from endometriosis. 2012
- Risk of carcinoma in women with ovarian endometrioma 2010
- Endometriosis and ovarian cancer: A review 2010
- Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis 2010
- Immunohistochemical expression of matrix metalloproteinases, their tissue inhibitors, and cathepsin-D in ovarian endometriosis: correlation with severity of disease 2010
- Endometriosis and ovarian cancer: A review 2009
- Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer 2009
- Association between MMP1 and MMP9 activities and ICAM1 cleavage induced by tumor necrosis factor in stromal cell cultures from eutopic endometria of women with endometriosis 2009
- Combating endometriosis by blocking proteasome and nuclear factor- B pathways 2008
- Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis 2006
- Estrogen receptor β and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis 2005
- Novel targets for the treatment of endometriosis 2004
- Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2 2004
- Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model 2004
- Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis 2004
- Endometriosis and the neoplastic process 2004
- Protein expression profiling of endometriosis: Validation of 2-mm tissue microarrays 2004
- (no title) 2003
- Ovarian endometriosis 2003
Source provenance
- europepmc
- last seen: 2026-09-09T06:15:24.302764+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:07.520820+00:00
License: CC0
· commercial use OK